The study about the prevalence of olfactory dysfunction related to allergic rhinitis and the effect by montelukast

The study about the prevalence of olfactory dysfunction related to allergic rhinitis and the effect by montelukast - The study about the effects on olfactory dysfunction by montelukast

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016063

Enrollment

100

Registered

2014-12-27

Start date

2012-07-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with allergic rhinitis and olfactory dysfunction

Exclusion criteria

Exclusion criteria: Patients with other nasal disease such as nasal polyp, severe nasal septim deviation, and infectious upper airway disease Patienst with non-allergic rhinitis Patients who are treated by medicines that affects nasal condition. Patients who are already treated on specific immunotherapy Patients who had been treatedby laser turbinectomy Patients who are already treated by allergic medicine such as steroid because of other allergic disease lactating or pregnancy women Patients whoom doctor decide as unappropriate for the study

Design outcomes

Primary

Measure	Time frame
The prevalence of patinets with olfactory dysfunction related to alergic rhinitis The improvement of olfactory dysfunction	—

Secondary

Measure	Time frame
The improvement nasal symptoms related to allergic rhinitis	—

Countries

Japan

Contacts

Public ContactYoshimasa Imoto

University of Fukui Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences

yimoto@u-fukui.ac.jp0776-61-8407

Outcome results